- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate efficacy of degarelix in achieving and maintaining testosterone suppression at castrate levels (≤0.5 ng/mL) during one year of treatment in prostate cancer patients.
Inclusion criteria
- Prostate cancer